WR Wealth Planners’s Novavax NVAX Stock Holding History

WR Wealth Planners’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21	Closed	-$152	–	625
2023 Q3	$152	Hold	21	–	–	﹤0.01%	885
2023 Q2	$156	Hold	21	–	–	﹤0.01%	876
2023 Q1	$146	Hold	21	–	–	﹤0.01%	905
2022 Q4	$216	Hold	21	–	–	﹤0.01%	474
2022 Q3	$382	Hold	21	–	–	﹤0.01%	452
2022 Q2	$1.08K	Hold	21	–	–	﹤0.01%	454
2022 Q1	$1.55K	Buy	+21	New	+$1.87K	﹤0.01%	443

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WR Wealth Planners's NVAX Position: Q4 2023 in Review

WR Wealth Planners sold out of Novavax (NVAX) in Q4 2023, closing a stake of 21 shares — an estimated $152 sold.

WR Wealth Planners first reported a position in NVAX in Q1 2022 and held it in 7 quarters. The position peaked at $1.55K in Q1 2022. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

WR Wealth Planners reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
WR Wealth Planners sold 21 Novavax shares in Q4 2023, an estimated $152.
WR Wealth Planners first reported a position in Novavax in Q1 2022 and held it in 7 quarters.
WR Wealth Planners's Novavax position peaked at $1.55K in Q1 2022.
199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on WR Wealth Planners's 13F filing for Q4 2023, filed 30 Jul 2024.